MKI67 and breast carcinoma: Clinical and preclinical studies evaluating the role of [18F]FLT in predicting treatment outcome have shown that in brain, lung, and breast cancers, there is a strong correlation between [18F]FLT uptake and the expression of the Ki-67 protein, a cellular marker for proliferation [42].